Attached files

file filename
EX-31 - EX-31.2 - Xtant Medical Holdings, Inc.ex-31d3411_edgar.htm
EX-31 - EX-31.1 - Xtant Medical Holdings, Inc.ex-31d3410_edgar.htm
EXCEL - IDEA: XBRL DOCUMENT - Xtant Medical Holdings, Inc.Financial_Report.xls
10-Q - 10-Q - Xtant Medical Holdings, Inc.form10-Q_edgar.htm
EX-32 - EX-32.1 - Xtant Medical Holdings, Inc.ex-32d3412_edgar.htm

Exhibit 32.2


Section 1350   Certification of Chief Financial Officer


In connection with the Quarterly Report on Form 10-Q of Bacterin International Holdings, Inc. (the “Company”) for the quarterly period ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Gandolfo, Chief Financial Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:


(1)              The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange  Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and


(2)              The information contained in the Report fairly presents, in all material respects, the financial condition  and results of operations of the Company.


/s/ John P. Gandolfo


John P. Gandolfo


Chief Financial Officer


Date:  November 7, 2014